E Fund Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
E Fund Management's ICPT Position: Q4 2023 in Review
E Fund Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 15,728 shares — an estimated $292K sold.
E Fund Management first reported a position in ICPT in Q1 2022 and held it in 7 quarters. The position peaked at $292K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- E Fund Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- E Fund Management sold 15,728 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $292K.
- E Fund Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2022 and held it in 7 quarters.
- E Fund Management's Intercept Pharmaceuticals, Inc. position peaked at $292K in Q3 2023.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on E Fund Management's 13F filing for Q4 2023, filed 7 Feb 2024.